Cita APA

Segovia, M., Russo, S., Jeldres, M., Mahmoud, Y. D., Perez, V., Duhalde, M., . . . Hill, M. (2019). Targeting TMEM176B enhances antitumor immunity and augments the efficacy of immune checkpoint blockers by unleashing inflammasome activation. Web

Citación estilo Chicago

Segovia, Mercedes, et al. Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers By Unleashing Inflammasome Activation. 2019.

Cita MLA

Segovia, Mercedes, et al. Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers By Unleashing Inflammasome Activation. 2019.